$AMRZ

Amrize 3Q 2026: Revenue $3.77B, Net income $559M, EPS $1.02— 10-Q Summary

Amrize reported Q3 2026 revenue of $3.77B, up 2.2% YoY, with net income at $559M (3.1% increase) and EPS at $1.02 (4.1% rise). Growth was driven by pricing, acquisitions, and surcharges, offset by lower volumes. Building Materials contributed 75.4% of revenue, while Building Envelope accounted for 24.6%.

Original reporting
Published Oct 29, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amrize 3Q 2026: Revenue $3.77B, Net income $559M, EPS $1.02— 10-Q Summary — source image
Decision brief

The 30-second read

$AMRZNeutralHigh
01

Why it matters

The earnings release offers fresh data for traders to reassess valuation and short‑term positioning.

02

Market read

The report supplies new earnings data for a mid‑cap industrial stock, creating a short‑term trading opportunity.

03

What to watch

The ASPIRE program's efficiency targets may improve margins in 2027, offering a longer-term upside not reflected in the immediate price.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Amrize Ltd filed its Form 10‑Q for Q3 2026, providing the first detailed financial snapshot for the quarter.

Company-level read

Ticker impact

$AMRZNeutralHigh confidence
Context

Amrize reported Q3 2026 revenue of $3.77B, net income $559M and EPS $1.02, the first public disclosure of these results.

Expected impact

likely modest upside as the beat may attract short-covering, but cost pressures could limit gains

Evidence & confidence

The numbers are better than prior year, but margin compression in a key segment tempers enthusiasm.

Market effects

Building materials sector may see slight uplift from pricing strength, but envelope segment cost concerns could weigh peers.

North American construction market exposure; limited broader regional effect.

Minimal global impact beyond sector-specific investors.

Counterpoint

Higher freight and raw material costs could erode profitability, suggesting a cautious stance despite top-line growth.

Key entities

  • Amrize Ltd

    Building materials and envelope manufacturer reporting Q3 2026 results.

Related articles

Med

Amrize Q3 2026 slides: pricing drives margins amid volume headwinds

Amrize reported Q3 2026 revenues of $3.77B, up 2.2% YoY, with net income rising 3.3% to $558M. Pricing initiatives and acquisitions offset volume declines due to weather. Building Materials segment grew 1.8%, while Building Envelope faced challenges. Guidance updated to $12.2B-$12.4B in revenue and $2.95B-$3.05B in adjusted EBITDA for 2026.

$AMRZMed

DA Davidson raises Amrize stock price target to $43 on mixed Q3

DA Davidson raised its price target for Amrize (NYSE:AMRZ) to $43, citing mixed Q3 results with strong Building Materials offset by Building Envelope pressure. The stock is up 5.5% weekly but down 22% in six months. Amrize guided below consensus but beat EPS estimates by 2.06% while missing revenue by 0.95%. DA Davidson maintains a Neutral rating, awaiting more execution visibility.

$AMRZHighAI 9/10

What Amrize (AMRZ) Said on Its Q3 Earnings Call

Amrize (AMRZ) reported Q3 revenue growth of 1.8% to $2.8B in Building Materials and 3.6% to $929M in Building Envelope. Adjusted EBITDA rose 2.7% in Building Materials but fell 14.6% in Building Envelope due to higher costs. The company expects price-over-cost positivity in Building Envelope by 2027. Amrize reaffirmed its 2026 outlook, targeting $12.2B-$12.4B in revenue and $2.95B-$3.05B in EBITDA. It returned $1.1B to shareholders through dividends and repurchases.

$AMRZMed

Amrize Ltd (AMRZ) Q3 2026 Earnings Call Highlights: Pricing Power Drives Growth

Amrize Ltd (AMRZ) reported Q3 2026 earnings, with revenue and EBITDA guidance updated to $12.2-$12.4B and $2.95-$3.05B. Cement volumes fell 4.2% YoY due to weather, while building envelope EBITDA declined 14.6% from inflation. Price-cost positivity in building envelope delayed to 2027. CEO Jan Jenisch expects 2027 growth but cites inflation and interest rate uncertainties. Free cash flow conversion below 50% target due to higher CapEx.

$AMRZMed

Amrize (AMRZ) Q3 2026 Earnings Call Transcript

Amrize (AMRZ) reported Q3 2026 earnings, highlighting strong pricing growth and operational efficiency. The company saw solid commercial roofing momentum but softer residential roofing due to lower home sales. Amrize completed $262M in CapEx and acquired PB Materials and Rapid Redi-Mix, strengthening its Texas market presence. The company returned $1.1B to shareholders via dividends and share repurchases, completing a $1B buyback program.

Med

Why is Amrize stock sliding today?

Amrize AG's stock is down 5.3% in pre-market trading after Q3 2026 results missed revenue expectations and the company lowered its full-year adjusted EBITDA guidance to $2.95–$3.05 billion. Revenue was $3.77 billion, up 2.2% YoY but below consensus. Management cited inflation-driven cost increases. The stock is near its 52-week low.